Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized trial of antimicrobial activity and safety of 0.5% chitosan mouth spray
TCTR20221129002Phase 1Unknown
- Sponsor
- Faculty of Dentistry, Khon Kaen University
- Start
- Dec 2022
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 1, randomised trial of chitosan in Oral bacterial infection, sponsored by Faculty of Dentistry, Khon Kaen University. Primary endpoints: Antimicrobial activity and Safety and tolerability. Status: unknown.
02
Drugs
chitosan
03
Conditions
Oral bacterial infection
Beyond the preview
Go deeper on TCTR20221129002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20221129002.